Uncovering Innovative Targets, Emerging Combinations, & Patient Phenotyping Approaches to Drive Tolerable, Differentiated,& Long-Term Efficacious Therapies through the Clinic
GLP-1s changed the treatment paradigm for obesity reaching new heights of efficacy. Now, as unmet need persists and the field looks beyond efficacy alone, momentum is building behind therapies that can deliver lasting weight management through improved tolerability, muscle preservation, personalised treatment approaches, and more convenient administration.
As obesity investment and pipeline activity surge across Europe, the 2nd Obesity & Weight Loss Drug Development Summit Europe is a unique opportunity to engage with the region's leading innovators and emerging stakeholders, advancing the next wave of obesity therapeutics beyond first-generation GLP-1s.
Unlike broad academic meetings, this industry-centred forum goes beyond data headlines to explore new MoA, combination therapies, tolerability improvements and critical lessons to define the 2nd generation of obesity & weight loss therapeutics and strengthen Europe’s footprint in this increasingly competitive global landscape
Join us to shape the next era of obesity care.
"The high quality of the presentations, industry focus and in-depth discussions combined with a concise number of participants allowing for fruitful networking and discussions"
Chief Scientific Officer, Cantoni Therapeutics, 2025 Attendee
“The quality of speakers and talks was excellent. The event was a great size for facilitating networking with everyone in the room”
Pipeline & Commercialisation Strategy Head, Constructive Bio, 2026 Attendee
“The agenda was excellent, with content on interesting approaches beyond long-acting GLP-1s. The discussions were also good and the speed networking was a great way of breaking the ice with multiple people”
Managing Director, MCTIS, 2025 Attendee
Explore the 2025 Full Event Guide
- Uncover top sessions across muscle mass maintenance, emerging modalities, combination therapies, expansive MoA and more
- Explore 8+ hours of networking opportunities to plan your time for maximum conversations
Official Partners - 2025
Attending Companies Included
Explore the Obesity Event Series
Explore the Agenda
Hear the latest GIP, amylin, mRNA and long-acting obesity therapeutic breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading European solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of in-depth, candid conversations in this carefully curated audience of like-minded drug development experts and make critical connections during our dedicated networking sessions